Back to results
US 12,370,255 B2Granted
Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
AssigneesBarinthus Biotherapeutics North America, Inc., The United States of America, AS Represented By the Secretary, Department of Health and Human Services Office of Technology Transfer, National Institutes of Health
InventorsGeoffrey Martin Lynn, Andrew Scott Ishizuka
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to novel peptide-based vaccines, methods of manufacturing the novel peptide-based vaccines and uses thereof for delivering peptide antigens to induce an immune response, and in particular a T cell response to a subject.
Claims1
A peptide antigen conjugate comprising a hydrophobic molecule represented by Formula (1):
Dependencies are inferred from the claim text.